| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/03/2006 | EP1651184A1 Fast dissolving orally consumable films containing pharmaceutically active agents |
| 05/03/2006 | EP1651169A2 Combination therapies for multiple sclerosis |
| 05/03/2006 | EP1651164A2 Composition and method for treating neurological disorders |
| 05/03/2006 | EP1651161A2 Pharmaceutical compositions and methods for accelerating wound healing |
| 05/03/2006 | EP1651038A2 Tissue adhesive sealant |
| 05/03/2006 | EP1553969B1 Use of ghrelin for treating malnutrition in gastrectomised individuals |
| 05/03/2006 | EP1501530A4 Prostaglandin f2 alpha analogs in combination with antimicrobial for treating glaucoma |
| 05/03/2006 | EP1448986B1 Conformation-activity relationship of apoptosis-inducing phosphodiester oligonucleotides |
| 05/03/2006 | EP1425046A4 Wild-type ras as a cancer therapeutic agent |
| 05/03/2006 | EP1389129A4 Methods of treating respiratory conditions |
| 05/03/2006 | EP1317273B1 Use of il-6r/il-6 chimera in huntington's disease |
| 05/03/2006 | EP1289383B1 Primary composition containing a lipophilic bioactive compound |
| 05/03/2006 | EP1253935B1 Use of placenta growth factor for preventing or treating ischemic diseases or stroke |
| 05/03/2006 | EP1242060B1 Treatment of metastatic disease |
| 05/03/2006 | EP1240822B1 Diabetes onset model mammal |
| 05/03/2006 | EP1189611B1 Cancer therapy |
| 05/03/2006 | EP1139755B1 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 05/03/2006 | EP1126863B1 Vascular endothelial growth factor-like protein from orf virus nz10 binds and activates mammalian vegf receptor-2 |
| 05/03/2006 | EP1107813B1 Kit for creating in situ, chemically cross-linked, mechanical barriers or covering structures for vascular puncture sites |
| 05/03/2006 | EP1105484B1 Antithrombin nucleotides and proteins from horn fly |
| 05/03/2006 | EP1104309B1 Co-lyophilized complex comprising a nucleic acid vector and a formulating agent |
| 05/03/2006 | EP1056459B1 Treatment of hiv infections |
| 05/03/2006 | EP1037923B9 Method for preparing by filtration a virally secure factor viii solution |
| 05/03/2006 | EP1015481B1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
| 05/03/2006 | EP0955995B1 Use of complexes for the preparation of compositions for the treatment of sensitive skin, preparation process and hypoallergenic compositions |
| 05/03/2006 | EP0955313B1 Novel protein and process for producing the same |
| 05/03/2006 | EP0810884B1 Treatment of vascular restenosis with inhaled nitric oxide |
| 05/03/2006 | EP0793500B1 Pharmaceutical compositions comprising nitric oxide-releasing polysaccharides |
| 05/03/2006 | EP0702717B1 Generation, concentration and efficient transfer of vsv-g pseudotyped retroviral vectors |
| 05/03/2006 | EP0625047B1 Platelet transfusion |
| 05/03/2006 | CN1768266A Methods for the purification of stable radioiodine conjugates |
| 05/03/2006 | CN1768145A Paramyxovirus vector encoding ribozyme and utilization thereof |
| 05/03/2006 | CN1768138A Method for producing recombinant proteins in micro-organisms |
| 05/03/2006 | CN1768079A Polypeptide |
| 05/03/2006 | CN1768076A Amyloid-beta(1-42) oligomers, derivatives thereof, antibodies for the same, method for production and use therof. |
| 05/03/2006 | CN1767856A Pharmaceutical compositions for hepatitis C viral protease inhibitors |
| 05/03/2006 | CN1767851A Hemoglobin conjugate and its preparing method and use |
| 05/03/2006 | CN1767850A Oral insulin composition and methods of making and using thereof |
| 05/03/2006 | CN1767849A Delivery system for drug and cell therapy |
| 05/03/2006 | CN1767848A Survivin-derived peptides and use thereof |
| 05/03/2006 | CN1767847A Treatment of aspergillus infections with thymosin alpha 1 |
| 05/03/2006 | CN1767846A Composition for the prevention and treatment of cellulitis |
| 05/03/2006 | CN1767815A Non-aqueous single phase vehicles and formulations utilizing such vehicles |
| 05/03/2006 | CN1766110A Miniaturized Staphylococcus aureus polypeptide of against drug resistance and its uses and preparation method |
| 05/03/2006 | CN1766107A Recombinant human keratinized cell growth factor production method |
| 05/03/2006 | CN1766106A Brain natriuretic peptide ú¿BNPú®preparation method |
| 05/03/2006 | CN1766100A Agkistrodonacutus thrombin preparation method and uses |
| 05/03/2006 | CN1766095A Probiotic composite enzyme production method |
| 05/03/2006 | CN1765932A Fusion protein of extrasin alpha1 and interferon |
| 05/03/2006 | CN1765931A GLP-1 fusion protein and its preparation method and medicinal uses |
| 05/03/2006 | CN1765929A Fusion protein and nucleic acid containing peptide carrier and epidermal growth factor and its uses |
| 05/03/2006 | CN1765928A Reconstituted human anti-hm1.24 antibody |
| 05/03/2006 | CN1765920A Gen-seng protein separation method and uses of the gen-seng protein |
| 05/03/2006 | CN1765417A Composition containing PVA-124 and its application |
| 05/03/2006 | CN1765371A Spleen extracts, its preparation method and use |
| 05/03/2006 | CN1765369A Nano silver gel and its use |
| 05/03/2006 | CN1765354A Three dimensional eye patch for treating eye wrinkles an its preparation method |
| 05/03/2006 | CN1254542C Methods for the recombinant production of antifusogenic peptides |
| 05/03/2006 | CN1254541C Novel compound |
| 05/03/2006 | CN1254540C Cloning and expression of Baimei pit viper Aidingbit CDNA for treating tumor |
| 05/03/2006 | CN1254535C Nano superoxide dismutase and preparation method |
| 05/03/2006 | CN1254487C Reformed monoclonal antibody for resisting immunoglobulin homoeotype |
| 05/03/2006 | CN1254486C Synthesis and expression of recombinant human parathyroxin gene |
| 05/03/2006 | CN1254485C Human lung cancer antigen and its antibody |
| 05/03/2006 | CN1254484C Solid-phase synthesis process of octreotide acetate |
| 05/03/2006 | CN1254478C Derivatives of monosaccharides as well adhesion inhibitors |
| 05/03/2006 | CN1254276C Matrix metalloproteinase inhibitors as targeting components in diagnostic agents |
| 05/03/2006 | CN1254275C Antithrombotic agent and anti-von willebrand factor monoclonal antibodies |
| 05/03/2006 | CN1254274C Recombinant hirudin oral enteric soluble slowly-releasing preparation |
| 05/03/2006 | CN1254273C Pharmaceutically stable hemostatic compositions |
| 05/03/2006 | CN1254272C Activation and inhibition of immune system |
| 05/03/2006 | CN1254271C Hybrid polypeptides with enhanced pharmacokinetic properties |
| 05/03/2006 | CN1254226C Face beautifying skin care compositions, its preparation method and uses |
| 05/02/2006 | USRE39086 Cosmetic use of botulinum toxin for treatment of downturned mouth |
| 05/02/2006 | US7038084 Viricides; Aids therapy |
| 05/02/2006 | US7038077 2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives; nervous system, psychological, and psychiatric disorders |
| 05/02/2006 | US7038035 Nucleic acids codes polypeptides; mutants; insertion a vector; culturing; recovering |
| 05/02/2006 | US7038022 Multimeric protein; complexing with steroids, thyroid; modulate transcription of genes under hormone expression control |
| 05/02/2006 | US7038020 Diagnosis of RH factor; using polypeptides to form antibodies |
| 05/02/2006 | US7038018 Antibodies and ligands for “Bonzo” chemokine receptor |
| 05/02/2006 | US7038017 Antibody purification |
| 05/02/2006 | US7038016 Dissolving a stable, activated polyoxyethylene glycol (carboxymethyloxy-end group)(aPEG) in a solvent; filtering the the solution to reduce the bioburden/endotoxin levels; used for the preparation of a PEGylated hemoglobin solution |
| 05/02/2006 | US7038015 Interferon gamma polypeptide variants |
| 05/02/2006 | US7038013 Nucleotide sequences coding polypeptide for use in treatment of immune respone defects |
| 05/02/2006 | US7038010 Agents and methods for promoting bone growth |
| 05/02/2006 | US7037941 Alpha-and Beta-amino acid hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors |
| 05/02/2006 | US7037907 Prodrug of an estradiol conjugated to a glucuronide sugar; 6-oxo-2-methoxyestradiol; 3-acetyl-6-oxo-2-methoxyestradiol; and 2-methoxyestradiol-6-hydrazone; angiogenesis inhibitor; antiinflammatory for asthma or rheumatoid arthritis |
| 05/02/2006 | US7037903 Administering an adenovirus expression vector, expressing a protein on cancer cells for treating ovarian cancer, cervical cancer, stomach cancer and lung cancer |
| 05/02/2006 | US7037902 Substituted triazolopyrimidine, pyridazinone, pyridine ordiazolohexahydroquinoline derivatives which bind to the erythropoietin receptor modulatin the domain of the recptor; bioassay |
| 05/02/2006 | US7037898 Tumor-activated prodrug compounds and treatment |
| 05/02/2006 | US7037897 TRI-, TETRA-, and penta-peptides having antiangiogenic activity |
| 05/02/2006 | US7037896 HIV inhibiting peptide (VIRIP) and amidated, acetylated, sulfated, polyethylene glycol modified, phosphorylated and/or glycosylated derivatives |
| 05/02/2006 | US7037895 Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction |
| 05/02/2006 | US7037894 Balancing physical properties of a polypeptide; obtain sample, crosslink tyrosine residues, monitor physical properties of polypeptide |
| 05/02/2006 | US7037893 Tetrapeptides identify multiple sclerosis antibodies; solid phase synthesis |
| 05/02/2006 | US7037892 Hematopoietic stem cell proliferating agents |
| 05/02/2006 | US7037891 Polypeptides; antidiabetic agents, cardiovascular disorders; hypotensive agent, antilipemic agents |
| 05/02/2006 | US7037890 For cancer therapy |
| 05/02/2006 | US7037889 Peptide and plurality of linked ligands that together form a water insoluble complex |
| 05/02/2006 | US7037888 Neuregulins bind the acetylcholine receptor which increases differentiation and survival of cardiac, skeletal and smooth muscle |